We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
UK-India Project Combats Infections Threat with Diagnostics
News

UK-India Project Combats Infections Threat with Diagnostics

UK-India Project Combats Infections Threat with Diagnostics
News

UK-India Project Combats Infections Threat with Diagnostics

Photo credit: Pixabay
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "UK-India Project Combats Infections Threat with Diagnostics"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

A £3 million interdisciplinary research project is to address the growing threat of drug-resistant infections in India.

The project will develop innovative diagnostics to curb antimicrobial resistance (AMR), one of the biggest threats to global public health.

AMR describes the situation when infections agents – including bacteria and parasites such as malaria – become resistant to the medicines used to treat them.

The DOSA programme – Diagnostics for One Health and User Driven Solutions for AMR – brings together nine leading academic institutions, five from India and four from the UK.

Medical researchers, diagnostic innovators, economists and social scientists will create cutting edge, rapid diagnostic solutions to fight AMR in settings as diverse as community healthcare, dairy farms and aquaculture.

Indian health issue


AMR is of particular concern in India, where the levels of infectious diseases are high but public knowledge of diseases and appropriate treatments is low.

In India, and across the globe, antibiotic use is regularly carried out without appropriate diagnostics, thereby fuelling the AMR crisis.

Rapid diagnostic tools are either unavailable, too expensive or do not fit people’s needs, which leads to antibiotics being used in a trial and error fashion.

Collaborative project


The three-year DOSA programme will begin with a meeting of the project group on 24-25 September at the Indian Institute of Technology Delhi.

The project is jointly funded by UK Research and Innovation/Economic and Social Research Council, the Newton Fund, and Government of India’s Department of Biotechnology.

Indian partners include the Indian Institute of Technology Delhi; the Centre for Cellular and Molecular Platforms Bangalore; ICAR-Central Institute of Fisheries Technology, Cochin, Kerala; ICAR-National Dairy Research Institute, Karnal, Haryana; Silchar Medical College and Assam University, Silchar, Assam.

UK partners include the Universities of Edinburgh, Bradford and Southampton and University of the Arts London.

Dr Till Bachmann, UK Project Coordinator, Division of Infection and Pathway Medicine, the University of Edinburgh, commented:

DOSA gives us the exceptional possibility to create a deep understanding between user needs and diagnostics innovation. The project will focus on community settings in India. It is here where the big drivers of AMR are located, where AMR is a huge burden and where it is exceptionally difficult to implement rapid diagnostics. 

This article has been republished from materials provided by The University of Edinburgh. Note: material may have been edited for length and content. For further information, please contact the cited source.
Advertisement